| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/25/2004 | EP1449850A1 Human cdr-grafted antibodies and antibody fragments thereof |
| 08/25/2004 | EP1449849A2 Protease-resistant thrombomodulin analog |
| 08/25/2004 | EP1449848A1 Method for the production of cystine-knot proteins |
| 08/25/2004 | EP1449542A1 Genetic remedies for neurodegenerative diseases |
| 08/25/2004 | EP1449539A2 Prophylactic or therapeutic use of a Fas antagonist to inhibit Fas-mediated apoptosis |
| 08/25/2004 | EP1449538A1 Inhibition of TACE or amphiregulin for the modulation of EGF receptor signal transactivation |
| 08/25/2004 | EP1449432A1 Nonhuman model animal of systemic lupus erythematosus |
| 08/25/2004 | EP1448984A2 Surface simulation synthetic peptides useful in the treatment of hyper-variable viral pathogens |
| 08/25/2004 | EP1448787A2 Human monoclonal antibodies to dendritic cells |
| 08/25/2004 | EP1448786A2 Process for preparing insulin compounds |
| 08/25/2004 | EP1448782A1 Optimized production of viral vectors derived from paroviruses in packaging and production cells by hsv infection or treatment with dna methylation inhibitors |
| 08/25/2004 | EP1448781A2 Method for identifying target epitopes of the t cell mediated immune response and for assaying epitope-specific t cells |
| 08/25/2004 | EP1448772A2 Methods of increasing protein expression levels |
| 08/25/2004 | EP1448760A2 Methods for monitoring polypeptide production and purification using surface enhanced laser desorption/ionization mass spectrometry |
| 08/25/2004 | EP1448603A2 Fusion proteins containing tlp peptides |
| 08/25/2004 | EP1448600A2 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy39 |
| 08/25/2004 | EP1448599A2 Inhibitors of the notch signalling pathway for use in the treatment of cancer |
| 08/25/2004 | EP1448598A2 Novel immunogenic mimetics of multimer proteins |
| 08/25/2004 | EP1448595A1 Antimicrobial polypeptides from pseudoplectania nigrella |
| 08/25/2004 | EP1448594A2 A food grade lantibiotic from streptococcus macedonicus and uses thereof |
| 08/25/2004 | EP1448593A2 Alpha-fetoprotein peptides and uses thereof |
| 08/25/2004 | EP1448589A2 Sperm-specific cation channel, catsper2, and uses therefor |
| 08/25/2004 | EP1448588A2 Psma antibodies and protein multimers |
| 08/25/2004 | EP1448583A2 A novel g protein-coupled receptor, gave8 |
| 08/25/2004 | EP1448227A2 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization |
| 08/25/2004 | EP1448223A2 Thymosin augmentation of genetic immunization |
| 08/25/2004 | EP1448218A2 Beta-secretase inhibitors and methods of use |
| 08/25/2004 | EP1448217A1 Methods for monitoring and guiding therapeutic suppression of parathyroid hormone in renal patients having secondary hyperparathyroidism |
| 08/25/2004 | EP1448056A2 Surfactant protein d for the prevention and diagnosis of pulmonary emphysema |
| 08/25/2004 | EP1444260A4 Secreted proteins and uses thereof |
| 08/25/2004 | EP1385942A4 Regulation of target protein activity through modifier proteins |
| 08/25/2004 | EP1283847A4 Pancreatic progenitor 1 gene and its uses |
| 08/25/2004 | EP1228235B1 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins |
| 08/25/2004 | EP1196593B1 Phage-resistant microorganisms and genetic determinants of phage resistance |
| 08/25/2004 | EP1190257B1 Early detection of flaviviruses using the ns1 glycoprotein |
| 08/25/2004 | EP1084136B1 Separation of antibody monomers from its multimers by use of ion-exchange chromatography |
| 08/25/2004 | EP1078066B1 Basb028 polypeptides and polynucleotides encoding therefor from moraxella catarrhalis |
| 08/25/2004 | EP1077719B1 Vaccine delivery system based on gonococcal blebosomes |
| 08/25/2004 | EP1066326B1 Process for the preparation of thromboplastin from animal tissue |
| 08/25/2004 | EP1064018B1 The use of isolated domains of type iv collagen to modify cell and tissue interactions |
| 08/25/2004 | EP1037657A4 Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same |
| 08/25/2004 | EP0893449B1 Antitumor substance extracted from hen-of-the-woods |
| 08/25/2004 | EP0839054B1 Tissue or cell-specific herpes simplex virus replication |
| 08/25/2004 | EP0830130B1 Tnf-alpha converting enzyme |
| 08/25/2004 | EP0826051B1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
| 08/25/2004 | EP0816380B1 Ocif protein and methods for the production of the same |
| 08/25/2004 | EP0724632B1 Stem cell proliferation factor |
| 08/25/2004 | EP0711361B1 5' nucleases derived from thermostable dna polymerase |
| 08/25/2004 | EP0700441B1 Multiple sclerosis virus |
| 08/25/2004 | CN1524128A DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such dna sequences |
| 08/25/2004 | CN1524124A Fibrin/fibrinogen-binding conjugate |
| 08/25/2004 | CN1524123A A soluble complex comprising a retroviral surface glycoprotein |
| 08/25/2004 | CN1524092A Concatameric immunoadhesion |
| 08/25/2004 | CN1524090A Modified insulin with reduced immunogenicity |
| 08/25/2004 | CN1524089A Nucleotide sequences which code for the rpsl gene |
| 08/25/2004 | CN1524088A A virus causing respiratory tract illness in susceptible mammals |
| 08/25/2004 | CN1523999A DNA expression vectors and methods of use |
| 08/25/2004 | CN1523996A Methods for reducing immunogenicity of polypeptides |
| 08/25/2004 | CN1523112A Tetracycline-regulated transcriptional modulators |
| 08/25/2004 | CN1523106A Method for preparing bacteria super antigen utilizing gene engineering means |
| 08/25/2004 | CN1523038A Separation method for plasma protein |
| 08/25/2004 | CN1523037A Method of eliminating endotoxin from interferon preparation |
| 08/25/2004 | CN1523036A Anti-coagulate protein and its coding gene and high effective expression method |
| 08/25/2004 | CN1163755C Diagnosis of demylelinating or spongiform disease |
| 08/25/2004 | CN1163754C Method for diagnosing a patient for chlamydia |
| 08/25/2004 | CN1163604C Gene 62 of attenuated varicella virus strain and method for identifying virus strain for attenuated live vaccine using the gene |
| 08/25/2004 | CN1163603C Enhanced internal translation factor of eukaryotic cell and its use |
| 08/25/2004 | CN1163602C Fusion protein of tubercle bacillus antigen, and its use |
| 08/25/2004 | CN1163601C Genome sequence of human efficient lymphocyte chemotactic factor and its preparing process |
| 08/25/2004 | CN1163600C Process for preparing human proinsulin |
| 08/25/2004 | CN1163597C Alpha-amylase mutant |
| 08/25/2004 | CN1163515C Novel affinity chromatography medium and purification method for cobra neurotoxin |
| 08/25/2004 | CN1163513C Process high effectively producing BPI-Fc recombinant protein |
| 08/25/2004 | CN1163510C Parathyroid hormone derivative and its preparing method |
| 08/25/2004 | CN1163509C RET ligand (RetL) for stimulating neural and renal growth |
| 08/25/2004 | CN1163508C Process for producing inhibin of tumor blood vessel formation |
| 08/25/2004 | CN1163507C Protease conjugates |
| 08/25/2004 | CN1163506C Novel human cell factor and its coding sequence and use |
| 08/25/2004 | CN1163504C Process for preparing resin-bound cyclic peptide |
| 08/25/2004 | CN1163268C Preparation of oral collagen of gradient molecular weight |
| 08/25/2004 | CN1163260C Ionic molecular conjugates of biodergaable polyesters and bioactive polypeptides |
| 08/25/2004 | CA2457389A1 Method of manufacturing t-20 and t-1249 peptides at commercial scale, and t-20 and t-1249 compositions related thereto |
| 08/24/2004 | US6781035 Leafy cotyledon1 genes and their uses |
| 08/24/2004 | US6781034 Stress tolerant plants |
| 08/24/2004 | US6781030 By combining a genome from an activated donor cell with an activated enucleated oocyte to obtain a nuclear transfer embryo, and impregnating an animal with the nuclear transfer embryo in conditions suitable for gestation of a cloned animal |
| 08/24/2004 | US6781029 Transgenic mouse for use as model in diagnosis and treatment of nervous and brain disorders |
| 08/24/2004 | US6781028 Animal models and methods for analysis of lipid metabolism and screening of pharmaceutical and pesticidal agents that modulate lipid metabolism |
| 08/24/2004 | US6780987 Nucleic acids molecules, designated beta cap73 nucleic acid molecules, which encode a novel actin binding protein; diagnostic and therapeutic methods utilizing compositions of the proteins |
| 08/24/2004 | US6780986 Human zinc finger protein rip60 ; isolated nucleic acid molecules, expression vectors containing these molecules and host cells transfected with the molecules |
| 08/24/2004 | US6780984 Diagnosing cancer in humans; obtain tissue sample, determine concentration of calreticulin in sample, compare to control, evaluate for cancer |
| 08/24/2004 | US6780983 Polypeptide having water channel activity and DNA sequence |
| 08/24/2004 | US6780979 Method for purifying PrPres from a biological sample and applications |
| 08/24/2004 | US6780977 Therapeutic, diagnostic and research utilities for these polynucleotides and proteins |
| 08/24/2004 | US6780975 Long wavelength engineered fluorescent proteins |
| 08/24/2004 | US6780974 Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors |
| 08/24/2004 | US6780973 Pure eotaxin dna sequence and eotaxin polypeptide, and methods of using such dna and polypeptide to direct chemotaxis of eosinophils; methods are provided for the treatment diseases and disorders such as inflammation and tumorigenesis |
| 08/24/2004 | US6780972 Reacting an acid addition salt of a basic starting peptide in the presence of a diluent in a mixed bed ion exchanger; forming a free peptide; and then forming the desired acid addition salt of the peptide |
| 08/24/2004 | US6780971 Compositions for inhibiting the aggregation pathway of α-synuclein |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780969 Peptide for use in the treatment of infections of the urogenital systems |